Aadi Biosciences, Inc.

The momentum for this stock is not very good. Aadi Biosciences, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Aadi Biosciences, Inc..
Log in to see more information.

News

Neil Desai Sells 40,000 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock
Neil Desai Sells 40,000 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock

Ticker Report Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) Chairman Neil Desai sold 40,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average...\n more…

Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 60.7% in August
Aadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 60.7% in August

Ticker Report Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the target of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 302,600...\n more…

Aadi Bioscience (NASDAQ:AADI) Downgraded to Neutral at Piper Sandler Companies
Aadi Bioscience (NASDAQ:AADI) Downgraded to Neutral at Piper Sandler Companies

Zolmax Piper Sandler Companies lowered shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday morning, Stock...\n more…

Aadi Bioscience (NASDAQ:AADI) Downgraded to Neutral at Piper Sandler Companies
Aadi Bioscience (NASDAQ:AADI) Downgraded to Neutral at Piper Sandler Companies

Ticker Report Piper Sandler Companies lowered shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday morning, Stock...\n more…

Aadi Bioscience (NASDAQ:AADI) Lowered to "Neutral" at Piper Sandler
Aadi Bioscience (NASDAQ:AADI) Lowered to "Neutral" at Piper Sandler

Ticker Report Piper Sandler cut shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from an overweight rating to a neutral rating in a report published on Tuesday morning, Marketbeat.com reports. Piper Sandler...\n more…

Aadi Bioscience (NASDAQ:AADI) Downgraded to "Hold" at Jefferies Financial Group
Aadi Bioscience (NASDAQ:AADI) Downgraded to "Hold" at Jefferies Financial Group

Zolmax Jefferies Financial Group cut shares of Aadi Bioscience (NASDAQ:AADI - Free Report) from a buy rating to a hold rating in a research note published on Wednesday morning, MarketBeat.com reports. They...\n more…